Page last updated: 2024-08-23

raloxifene hydrochloride and ergoline

raloxifene hydrochloride has been researched along with ergoline in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akbari, H; Alaei-Shahmiri, F; Asadi, P; Ghorbani, M; Honardoost, M; Imani, M; Kaynama, MR; Khamseh, ME; Malek, M1

Trials

1 trial(s) available for raloxifene hydrochloride and ergoline

ArticleYear
COMPARISON OF CABERGOLINE VERSUS RALOXIFENE ADD-ON THERAPY TO LONG-ACTING SOMATOSTATIN ANALOGUE IN PATIENTS WITH INADEQUATELY CONTROLLED ACROMEGALY: A RANDOMIZED OPEN LABEL CLINICAL TRIAL.
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2018, Volume: 24, Issue:6

    Topics: Acromegaly; Adult; Blood Pressure; Cabergoline; Ergolines; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Logistic Models; Male; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Somatostatin

2018